Brigatinib ( DrugBank: Brigatinib )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
34神経線維腫症1

34. 神経線維腫症


臨床試験数 : 137 薬物数 : 213 - (DrugBank : 76) / 標的遺伝子数 : 87 - 標的パスウェイ数 : 200
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04374305
(ClinicalTrials.gov)
June 20, 202030/4/2020Innovative Trial for Understanding the Impact of Targeted Therapies in NF2Innovative Trial for Understanding the Impact of Targeted Therapies in NF2 (INTUITT-NF2)Neurofibromatosis Type 2;Vestibular Schwannoma;Non-vestibular Schwannoma;Meningioma;EpendymomaDrug: BrigatinibScott R. Plotkin, MD, PhDTakeda;The Children's Tumor FoundationRecruiting12 YearsN/AAll80Phase 2United States